Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
Showing 781–840 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
…itivity consistently included upregulation of interferon alpha, interferon gamma and cholesterol homeostasis.For clinical manifestations, serosi…
…allis test and logistic regression.Results Among the refractory BILAG-BR cohort, 40% were positive for IgA2 anti-dsDNA (AU >= 12.5), com…
… months, 56.3% for >5 years and 20.4% for >10 years. Persistent hydroxychloroquine use (adjusted HR: 1.70, p=0.014) and absence of renal flares pr…
…regimen was intravenous Methylprednisolone pulses combined with Mycophenolate Mofetil. Partial remission was achieved in 100% of patients (2.7 months…
…d PDC showed moderate agreement (Cohen’s Kappa 0.424, p=0.016). Hydroxychloroquine adherence was lower in nonadherent patients (PDC 33.3% vs 94.4%…
…bodies in 73.2%.Regarding treatment, 85.1% of patients received antimalarials and 95.8% systemic corticosteroids. Conventional immunosuppress…
…y and were on therapeutic vacation period (2 teriperatide and 1 denosumab). Among classical risk factors, 12.1% were smokers (5% former a…
…beta = -1.39), lower educational attainment (beta = -7.02), and prednisolone use (beta = -1.85) were independently associated with lower PCS…
…vity (LLDAS), surpassing classic biomarkers like anti-dsDNA and SLEDAI. Mixed-effects logistic regression yielded data-driven cut-offs…
…Objectives Methylprednisolone (mPSL) pulse therapy is an essential treatment for systemic lup…
…s pooled individual patient data from the placebo arms of three anifrolumab trials (MUSE, TULIP-1, TULIP-2). The SLE-DAS RI was defined as …
…8). Musculoskeletal and ophthalmologic domains, often linked to glucocorticoid exposure, contributed most to non-renal damage.Abstract S9:05 F…